Allopurinol

Allopurinol is a xanthine oxidase inhibitor that reduces uric acid production by blocking purine catabolism, making it a first-line therapy for chronic gout and hyperuricemia. Simson Pharma's Allopurinol reference standard and impurities support the compendial and stability-indicating testing demanded of this widely prescribed generic.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Allopurinol Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Allopurinol
Allopurinol EP Impurity A
Allopurinol EP Impurity B
Allopurinol EP Impurity B Monohydrate
Allopurinol EP Impurity C
Allopurinol EP Impurity D
Allopurinol EP Impurity E
Allopurinol USP Related Compound F
Allopurinol Related Compound A
Oxypurinol
3-Morpholino-2-cyanoacrylamide
Allopurinol Riboside
2-Cyano-3-Ethoxy-Acrylic Acid Ethyl Ester
Allopurinol Impurity 3
1-Nitroso-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one
(E)-2-cyano-3-(dimethylamino)acrylamide
(Z)-2-Cyano-3-Morpholinoacrylamide
Allopurinol Impurity 2
Allopurinol Impurity 5
Allopurinol EP Impurity A Sulfate
Allopurinol N-Nitroso Pyrazole amide Impurity
N-Nitroso Allopurinol Impurity B
Allopurinol Nitroso Impurity 1
Allopurinol Nitroso Impurity 2
Allopurinol Nitroso Impurity 3

Isotope Labelled Compounds

Allopurinol-D2
Oxypurinol 13C,15N2
Allopurinol-13C,15N2
Allopurinol-13C,15N2, D2
Allopurinol-13C3-15N